Winter 2020

Jennifer Adair ('05 PhD, School of Molecular Biosciences) had never heard of Pullman when she considered WSU’s National Institute of Health Protein Biotechnology Training Program. She even shamefully admits, at first, she confused WSU with the University of Washington. Now, the Coug is developing gene therapies to treat genetic disorders, HIV and cancer. Adair is a faculty member in the Clinical Research Division at the Fred Hutchinson Cancer Research Center in Seattle. Her goal: provide safe, cost-effective applications for gene therapy that can be implemented worldwide.

When Washington State University doctoral student Kaitlin Witherell was a child, she frequently went to work with her scientist mother. Through her young eyes and vivid imagination, she watched her mother complete complex calculations that filled entire pages, make exotic and colorful solutions, and use alien-like equipment that seemed more magical than practical.

If not identified before surgery, a rare genetic mutation could result in your dog being exposed to dangerously high levels of anesthetic agents.

Scientists at Washington State University’s College of Veterinary Medicine initially discovered the mutation in greyhounds and more recently in other common dog breeds.